These 3 Biotechs Could Have the Most Exciting Late-Stage Cancer Candidates Post author:Sam Post published:August 21, 2017 Post category:BioPharma August 22, 2017By Mark Terry, BioSpace.com Breaking… Source: BioSpace You Might Also Like Nestle Emerges as the Frontrunner for Merck KGaA's $5B Consumer Health Biz January 9, 2018 KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly January 4, 2018 Celgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial February 5, 2018
KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly January 4, 2018
